Autor: |
Leeksma AC; Amsterdam University Medical Centers, University of Amsterdam., Baliakas P; Dept of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Sweden., Moysiadis T; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Puiggros A; Hospital del Mar, Barcelona., Plevova K; University Hospital Brno, Masaryk University, Brno, Czech Republic., Van der Kevie-Kersemaekers AM; Dept of Clinical Genetics, Amsterdam University Medical Centers, Univ of Amsterdam, The Netherlands., Posthuma H; Dept of Clinical Genetics, Amsterdam University Medical Centers, Univ of Amsterdam, The Netherlands., Rodriguez-Vicente AE; IBSAL, IBMCC, Centro de Investigación del Cancer, Universidad de Salamanca-CSIC, Spain., Tran AN; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Barbany G; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Mansouri L; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Gunnarsson R; Division of Clinical Genetics, Dept of Laboratory Medicine, Lund University, Lund, Sweden., Parker H; Cancer Genomics, Academic Unit of Cancer Sciences, University of Southampton, Southampton, UK., Van den Berg E; Dept of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands., Bellido M; Dept of Genetics, University Medical Center Groningen, University of Groningen, The Netherlands., Davis Z; Dept of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Wall M; Cytogenetics department, St Vincent Hospital Melbourne, Victoria, Australia., Scarpelli I; Oncogenomic laboratory, Dept of Hematology, Lausanne University Hospital (CHUV), Switzerland., Österborg A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Hansson L; Department of Oncology-Pathology, Karolinska Institutet, Stockholm., Jarosova M; University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Ghia P; Dept. of Experimental Oncology, IRCCS Ospedale San Raffaele, Università Vita-Salute, Milan., Poddighe P; Amsterdam University Medical Centers, Vrije Universiteit Amsterdam, The Netherlands., Espinet B; Laboratori de Citogenetica Molecular, Servei de Patologia, Hospital del Mar, Barcelona, Spain., Pospisilova S; CEITEC, University Hospital Brno and Faculty of Medicine, Masaryk University, Brno, Czech Republic., Tam C; St Vincent Hospital Melbourne, Peter MacCallum Cancer Center, University of Melbourne, Australia., Ysebaert L; Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France., Nguyen-Khac F; Service d'Hematologie Biologique, Hopital Pitié-Salpetriere, APHP, Paris, France., Oscier D; Dept of Molecular Pathology, Royal Bournemouth Hospital, Bournemouth, UK., Haferlach C; MLL Munich Leukemia Laboratory, Munich, Germany., Schoumans J; Oncogenomic laboratory, Dept of Hematology, Lausanne University Hospital (CHUV), Switzerland., Stevens-Kroef M; Radboud University Medical Center, Dept of Human Genetics, Nijmegen, The Netherlands., Eldering E; Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Stamatopoulos K; Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki, Greece., Rosenquist R; Dept of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden., Strefford JC; Cancer Genomics, Academic Unit of Cancer Sciences, University of Southampton., Mellink C; Amsterdam University Medical Centers, University of Amsterdam, The Netherlands., Kater AP; Hematology, Amsterdam University Medical Centers, University of Amsterdam, The Netherlands. |